Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for primary packaging labeling, secondary packaging, control/testing of batch and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for palliative therapy of brain tumors (primary and metastatic), lung tumors (especially small cell carcinoma), Hodgkin's disease that is resistant to traditional treatment, malignant melanoma with metastases, and as a second-line agent in the treatment of non-Hodgkin lymphoma.
Dosage form: capsules
Active substance Dosage lomustine 40 mg ATC: L01AD02
-
It is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 2.5 mg -
The drug is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 7.5 mg -
The drug is used for the treatment of active rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute lymphoblastic leukemia.
Dosage form: tablets
Active substance Dosage methotrexate 10 mg